QA: JOHNSON & JOHNSON in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2019_JOHNSON_JOHNSON.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000200406, JOHNSON & JOHNSON

  xvar xval
0 AssetsCurrent 46,033,000,000
1 IntangibleAssetsNetIncludingGoodwill 78,064,000,000
2 PropertyPlantAndEquipmentNet 17,035,000,000
3 remainder_Assets 11,822,000,000
4 LiabilitiesCurrent 31,230,000,000
5 LiabilitiesNoncurrent 36,273,000,000
6 remainder_Liabilities 25,699,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,540,000,000
9 ResearchAndDevelopmentExpense 10,775,000,000
10 remainder_Expenses 32,175,000,000
11 remainder_Revenues 81,581,000,000
12 remainder_NetIncome -794,000,000
13 remainder_ComprehensiveNetIncome -1,791,000,000
  yvar yval
0 Assets 152,954,000,000
1 Liabilities 93,202,000,000
2 Expenses 65,490,000,000
3 Revenues 81,581,000,000
4 StockholdersEquity 59,752,000,000
5 NetIncome 15,297,000,000
6 ComprehensiveNetIncome 14,401,500,000
7 BaseVar 197,906,000,000
8 EconomicCapitalRatio 0.952

Edgar->Model Mapping

Feature Distribution

Change over Time